Mehtab Munir, Ayesha Khan, Tauseef Sayyar, Mariam Mufti, Iqra Siddiqui, Sara Tariq Abbasi
{"title":"萘普生和双醋瑞因治疗膝关节骨关节炎的比较","authors":"Mehtab Munir, Ayesha Khan, Tauseef Sayyar, Mariam Mufti, Iqra Siddiqui, Sara Tariq Abbasi","doi":"10.37939/jrmc.v27i3.2034","DOIUrl":null,"url":null,"abstract":"Background: Knee osteoarthritis is a common disease in older age. Pain and limitation of movement are the main symptoms of knee osteoarthritis. Many pharmacological options are available for symptomatic relief but NSAIDs are mostly prescribed. Diacerein is also prescribed for osteoarthritis but data regarding its efficacy is still controversial. Moreover, studies regarding the comparison of diacerein with NSAIDs are deficient in Pakistan. Objective: The objective of the study was to compare the clinical efficacy of naproxen (NSAID) with diacerein in treating knee osteoarthritis. Methodology: Patients fulfilling inclusion criteria were included in the study. After written informed consent 60 patients of knee osteoarthritis were included in the study. They were divided randomly into two groups. Group A (n=30) was prescribed with tablet naproxen 500mg twice daily and group B (n=30) was given capsule diacerein 50mg twice daily for 12 weeks. Baseline VAS and WOMAC scores of the patients were noted. These scores were compared with scores achieved 12 weeks after intervention. Intra-group comparison of the scores was also carried out. SPSS version 23.0 was used for statistical analysis. Results: WOMAC and VAS scores comparison of the two groups (A & B) before intervention showed an insignificant p-value that is 0.815 for the WOMAC score and 0.509 for the VAS score. After intervention means WOMAC score i.e.10.50 ± 2.46 of group A (treated with naproxen) was better than the mean 29.62 ± 7.03 of group B (treated with diacerein) showing significant p-value (< 0.001). Similarly mean VAS of group A 1.92 ± 0.58 improved more than the mean VAS of group B i.e 3.38 ± 0.75 with significant p-value (< 0.001). Intra-group comparison of the groups also showed a significant p-value. Conclusion: Clinical efficacy of naproxen is better than diacerein in treating knee osteoarthritis.","PeriodicalId":34174,"journal":{"name":"Journal of Rawalpindi Medical College","volume":"146 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison Of Naproxen And Diacerein In The Treatment Of Knee Joint Osteoarthritis\",\"authors\":\"Mehtab Munir, Ayesha Khan, Tauseef Sayyar, Mariam Mufti, Iqra Siddiqui, Sara Tariq Abbasi\",\"doi\":\"10.37939/jrmc.v27i3.2034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Knee osteoarthritis is a common disease in older age. Pain and limitation of movement are the main symptoms of knee osteoarthritis. Many pharmacological options are available for symptomatic relief but NSAIDs are mostly prescribed. Diacerein is also prescribed for osteoarthritis but data regarding its efficacy is still controversial. Moreover, studies regarding the comparison of diacerein with NSAIDs are deficient in Pakistan. Objective: The objective of the study was to compare the clinical efficacy of naproxen (NSAID) with diacerein in treating knee osteoarthritis. Methodology: Patients fulfilling inclusion criteria were included in the study. After written informed consent 60 patients of knee osteoarthritis were included in the study. They were divided randomly into two groups. Group A (n=30) was prescribed with tablet naproxen 500mg twice daily and group B (n=30) was given capsule diacerein 50mg twice daily for 12 weeks. Baseline VAS and WOMAC scores of the patients were noted. These scores were compared with scores achieved 12 weeks after intervention. Intra-group comparison of the scores was also carried out. SPSS version 23.0 was used for statistical analysis. Results: WOMAC and VAS scores comparison of the two groups (A & B) before intervention showed an insignificant p-value that is 0.815 for the WOMAC score and 0.509 for the VAS score. After intervention means WOMAC score i.e.10.50 ± 2.46 of group A (treated with naproxen) was better than the mean 29.62 ± 7.03 of group B (treated with diacerein) showing significant p-value (< 0.001). Similarly mean VAS of group A 1.92 ± 0.58 improved more than the mean VAS of group B i.e 3.38 ± 0.75 with significant p-value (< 0.001). Intra-group comparison of the groups also showed a significant p-value. Conclusion: Clinical efficacy of naproxen is better than diacerein in treating knee osteoarthritis.\",\"PeriodicalId\":34174,\"journal\":{\"name\":\"Journal of Rawalpindi Medical College\",\"volume\":\"146 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Rawalpindi Medical College\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37939/jrmc.v27i3.2034\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rawalpindi Medical College","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37939/jrmc.v27i3.2034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:膝关节骨关节炎是一种常见的老年疾病。疼痛和活动受限是膝关节骨关节炎的主要症状。有许多药物可用于缓解症状,但非甾体抗炎药是最常用的处方药。双醋瑞因也是治疗骨关节炎的处方药,但有关其疗效的数据仍存在争议。此外,巴基斯坦还缺乏关于双醋瑞因和非甾体抗炎药的比较研究。 研究目的本研究旨在比较萘普生(非甾体抗炎药)和迪卡瑞在治疗膝骨关节炎方面的临床疗效。 研究方法:研究对象包括符合纳入标准的患者。在获得书面知情同意后,60 名膝关节骨关节炎患者被纳入研究。他们被随机分为两组。A 组(30 人)服用片剂萘普生 500 毫克,每天两次;B 组(30 人)服用胶囊剂迪卡色林 50 毫克,每天两次,连续服用 12 周。记录患者的基线 VAS 和 WOMAC 评分。将这些评分与干预 12 周后的评分进行比较。此外,还进行了组内评分比较。统计分析采用 SPSS 23.0 版。 结果干预前两组(A 组和 B 组)的 WOMAC 和 VAS 评分比较显示,WOMAC 评分的 p 值为 0.815,VAS 评分的 p 值为 0.509,差异不大。干预后,A 组(使用萘普生治疗)的 WOMAC 平均得分(10.50 ± 2.46)优于 B 组(使用迪卡瑞林治疗)的平均得分(29.62 ± 7.03),P 值显著(< 0.001)。同样,A 组的 VAS 平均值(1.92 ± 0.58)比 B 组的 VAS 平均值(3.38 ± 0.75)改善得更多,P 值显著(< 0.001)。各组的组内比较也显示出显著的 p 值。 结论在治疗膝骨关节炎方面,萘普生的临床疗效优于迪卡瑞林。
Comparison Of Naproxen And Diacerein In The Treatment Of Knee Joint Osteoarthritis
Background: Knee osteoarthritis is a common disease in older age. Pain and limitation of movement are the main symptoms of knee osteoarthritis. Many pharmacological options are available for symptomatic relief but NSAIDs are mostly prescribed. Diacerein is also prescribed for osteoarthritis but data regarding its efficacy is still controversial. Moreover, studies regarding the comparison of diacerein with NSAIDs are deficient in Pakistan. Objective: The objective of the study was to compare the clinical efficacy of naproxen (NSAID) with diacerein in treating knee osteoarthritis. Methodology: Patients fulfilling inclusion criteria were included in the study. After written informed consent 60 patients of knee osteoarthritis were included in the study. They were divided randomly into two groups. Group A (n=30) was prescribed with tablet naproxen 500mg twice daily and group B (n=30) was given capsule diacerein 50mg twice daily for 12 weeks. Baseline VAS and WOMAC scores of the patients were noted. These scores were compared with scores achieved 12 weeks after intervention. Intra-group comparison of the scores was also carried out. SPSS version 23.0 was used for statistical analysis. Results: WOMAC and VAS scores comparison of the two groups (A & B) before intervention showed an insignificant p-value that is 0.815 for the WOMAC score and 0.509 for the VAS score. After intervention means WOMAC score i.e.10.50 ± 2.46 of group A (treated with naproxen) was better than the mean 29.62 ± 7.03 of group B (treated with diacerein) showing significant p-value (< 0.001). Similarly mean VAS of group A 1.92 ± 0.58 improved more than the mean VAS of group B i.e 3.38 ± 0.75 with significant p-value (< 0.001). Intra-group comparison of the groups also showed a significant p-value. Conclusion: Clinical efficacy of naproxen is better than diacerein in treating knee osteoarthritis.